These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14111755)

  • 1. [COMPARISON OF SOME EFFECTS OF HEPARIN AND THE PERORAL HEPARINOID "ATEROID" IN RATS].
    CEPELIK J; CERNOHORSKY M
    Cas Lek Cesk; 1963 Nov; 102():1291-4. PubMed ID: 14111755
    [No Abstract]   [Full Text] [Related]  

  • 2. [HEPARINOIDS--PHYSIOLOGICAL PROPERTIES AND THERAPEUTIC INDICATIONS].
    GUILLEMAN P; HARDY N
    Rev Prat; 1964 Oct; 14():3391-405. PubMed ID: 14205831
    [No Abstract]   [Full Text] [Related]  

  • 3. [On influencing the physiological coagulation time and the clearing factor by total body inunction with alpha-heparin and heparinoid ointments].
    STUETTGEN G; BRUESTER H
    Dermatol Wochenschr; 1960 Jan; 141():97-102. PubMed ID: 13835417
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDIES ON THE CLEARANCE INDUCING EFFECTS OF A NATURAL HEPARINOID].
    WAGENER H; KRUSZEWSKA B; SCHULZ U
    Arzneimittelforschung; 1964 Aug; 14():879-83. PubMed ID: 14344130
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECT OF HEPARIN AND HEPARINOIDS ON THE SYNTHESIS OF ALDOSTERONE AND CORTICOSTERONE BY THE RAT ADRENAL GLAND.
    GLAZ E; SUGAR K
    Endocrinology; 1964 Feb; 74():159-64. PubMed ID: 14122519
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACTION OF THE HEPARINOID, CB-8061, IN MAN. I. APPEARANCE OF PLASMA CLEARING CAPACITY AFTER INJECTION OF A SINGLE DOSE OF THE PRODUCT].
    DUREUX JB; BRIGNON JJ; MARCHAL C
    Therapie; 1964; 19():879-89. PubMed ID: 14190943
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the behavior of the plasma "clearing factor" after the administration of a synthetic heparinoid].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1498-9. PubMed ID: 13807122
    [No Abstract]   [Full Text] [Related]  

  • 8. [COMPARATIVE STUDIES OF THE EFFECT OF HEPARIN AND SP 54 ON DYESTUFF-HYALURONIDASE SPREADING].
    MATHIES H; WILLMS D
    Med Monatsschr; 1965 Jan; 19():38-9. PubMed ID: 14270693
    [No Abstract]   [Full Text] [Related]  

  • 9. [BLOOD LIPOPROTEIN LIPASE AND ITS PROPERTIES AS A COMPONENT OF THE PHYSIOLOGICAL ANTICOAGULANT SYSTEM].
    KUDRIASHOV BA; BAZAZIAN GG; BONFITTO LL
    Vopr Med Khim; 1963; 9():533-5. PubMed ID: 14088160
    [No Abstract]   [Full Text] [Related]  

  • 10. SERUM REQUIREMENT FOR RELEASE OF HEPARIN-INDUCED LIPASE FROM PERFUSED RAT HEART.
    CRASS MF; MENG HC
    Am J Physiol; 1964 Mar; 206():610-4. PubMed ID: 14162310
    [No Abstract]   [Full Text] [Related]  

  • 11. THE EFFECT OF HEPARIN, HEPARINOIDS, AND OTHER ELECTRONEGATIVE COMPOUNDS ON THE IN VITRO THROMBIN-FIBRINOGEN CONVERSION AND ON WHOLE BLOOD CLOTTING TIME.
    SALAFSKY B; LOOMIS TA
    Arch Int Pharmacodyn Ther; 1964 Jul; 150():107-17. PubMed ID: 14204484
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
    SCHOEN H
    Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657
    [No Abstract]   [Full Text] [Related]  

  • 13. [LIPOPROTEIN LIPASE AS A HUMORAL AGENT OF THE PHYSIOLOGICAL ANTICOAGULATING SYSTEM].
    KUDRIASHOV BA; BAZAZIAN GG; TRAPEZNIKOVA SS; NOSOVA VN
    Biull Eksp Biol Med; 1963 May; 55():20-5. PubMed ID: 14077737
    [No Abstract]   [Full Text] [Related]  

  • 14. LIPOLYTIC ACTIVITY IN THE BLOOD AFTER LIPASE INGESTION.
    TIDWELL HC; MCPHERSON JC; MOORE WT; POPE JL; FREEMAN A
    Proc Soc Exp Biol Med; 1964 Jul; 116():720-3. PubMed ID: 14194643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological studies on heparinoid SP 54].
    ODA T; YOSHIMOTO S
    Osaka City Med J; 1962 Dec; 11():319-25. PubMed ID: 13939447
    [No Abstract]   [Full Text] [Related]  

  • 16. PERCUTANEOUS ABSORPTION OF HEPARIN IN RABBIT'S EAR.
    KONTTINEN Y
    Ann Med Exp Biol Fenn; 1965; 43():43-8. PubMed ID: 14312355
    [No Abstract]   [Full Text] [Related]  

  • 17. DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA.
    BOBERG J; CARLSON LA
    Clin Chim Acta; 1964 Nov; 10():420-7. PubMed ID: 14230938
    [No Abstract]   [Full Text] [Related]  

  • 18. [ANTICOAGULANT DRUG THERAPY IN MYOCARDIAL INFARCT].
    MATSUOKA S; HOMMA T
    Sogo Rinsho; 1964 Mar; 13():463-71. PubMed ID: 14140834
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect on fat metabolism of a new heparinoid of fungal origin.
    Tamási G; Cseh G; Szabó IK; Villányi K
    Acta Physiol Acad Sci Hung; 1968; 33(2):205-12. PubMed ID: 4175991
    [No Abstract]   [Full Text] [Related]  

  • 20. THE ANTITHROMBOSIS ACTIVITY OF THE HEPARINOID G 31150.
    JARRETT CL; JAQUES B
    Thromb Diath Haemorrh; 1964 Jan; 10():431-7. PubMed ID: 14113382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.